HLA Class I–sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes

Abstract

Anti-HLA antibodies cross-react with SLA class I in predictable patterns, which can be identified with histocompatibility strategies, and SLA class I is a possible target of genetic engineering.